<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02053129</url>
  </required_header>
  <id_info>
    <org_study_id>CIDRZ 1217/IRB12-0417</org_study_id>
    <nct_id>NCT02053129</nct_id>
  </id_info>
  <brief_title>Evaluation of PTB Screening in ANC in Lusaka, Zambia</brief_title>
  <official_title>Pilot Evaluation of Pulmonary Tuberculosis Screening in Antenatal Clinics in Lusaka, Zambia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre for Infectious Disease Research in Zambia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot pulmonary TB screening program done in three antenatal care clinics in
      Lusaka, Zambia to determine the prevalence of culture-confirmed pulmonary tuberculosis and to
      determine the sensitivity and specificity of symptom-based TB screening.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      5000 pregnant women attending antenatal clinics will be evaluated by piloting a TB symptom
      questionnaire as part of the general health screening done at each visit. Due to the atypical
      and subclinical presentation of TB in HIV infected patients, culture will be performed on all
      HIV-infected pregnant women, with or without symptoms, and on all symptomatic HIVnegative
      women. Referrals for TB treatment in accordance with current national guidelines will be
      offered.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of positive pulmonary tuberculosis (PTB) tests</measure>
    <time_frame>1 day of screening (first antenatal visit)</time_frame>
    <description>The prevalence of culture confirmed PTB among HIV positive and HIV negative pregnant women will be measured to determine if there is a substantial amount of undiagnosed TB in the HIV positive population accessing antenatal care.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and specificity of symptom-based TB screening</measure>
    <time_frame>1 day of screening visit</time_frame>
    <description>To determine the sensitivity and specificity of symptom based TB screening (compared to TB culture), enrollees will have TB symptoms assessed by administration of a questionnaire. Culture will then be performed on all HIV infected pregnant women, with or without symptoms, and on all symptomatic HIV negative women.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5033</enrollment>
  <condition>Pulmonary Tuberculosis</condition>
  <arm_group>
    <arm_group_label>HIV negative pregnant women</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Pregnant women who are HIV negative attending their first ANC visit</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV positive pregnant women</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Pregnant women who are HIV positive accessing antenatal care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>TB screening Questionnaire</intervention_name>
    <description>All subjects will be screened with the questionnaire which assesses TB symptoms.</description>
    <arm_group_label>HIV negative pregnant women</arm_group_label>
    <arm_group_label>HIV positive pregnant women</arm_group_label>
    <other_name>Pilot TB symptom questionnaire</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sputum smear and culture (only in HIV negative women who are symptomatic)</intervention_name>
    <description>specimens for sputum microscopy and culture collected and processed in accordance with WHO TB Infection Control Guidelines</description>
    <arm_group_label>HIV positive pregnant women</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women

          -  18 years or older

          -  HIV-negative women with any TB symptoms or HIV-infected women regardless of TB
             symptoms

          -  Attending first ANC visit at one of program clinics

        Exclusion Criteria:

          -  HIV negative without any TB symptoms
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stewart Reid, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Infectious Disease Research in Zambia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nzali Kancheya, MMED, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Infectious Disease Research in Zambia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Saag, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor, University of Alabama</affiliation>
  </overall_official>
  <overall_official>
    <last_name>German Henostroza, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Infectious Disease Research in Zambia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Annika Kruuner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Infectious Disease Research in Zambia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre for Infectious Disease Research in Zambia</name>
      <address>
        <city>Lusaka</city>
        <country>Zambia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Zambia</country>
  </location_countries>
  <link>
    <url>http://www.unc.edu</url>
    <description>University of North Carolina website</description>
  </link>
  <reference>
    <citation>Global tuberculosis control: Epidemiology, Strategy, Financing. WHO report 2009. 2009, World Health Organization: Geneva, Switzerland.</citation>
  </reference>
  <reference>
    <citation>Black V, Brooke S, Chersich MF. Effect of human immunodeficiency virus treatment on maternal mortality at a tertiary center in South Africa: a 5-year audit. Obstet Gynecol. 2009 Aug;114(2 Pt 1):292-9. doi: 10.1097/AOG.0b013e3181af33e6.</citation>
    <PMID>19622990</PMID>
  </reference>
  <reference>
    <citation>Mwaba P, Maboshe M, Chintu C, Squire B, Nyirenda S, Sunkutu R, Zumla A. The relentless spread of tuberculosis in Zambia--trends over the past 37 years (1964-2000). S Afr Med J. 2003 Feb;93(2):149-52.</citation>
    <PMID>12640889</PMID>
  </reference>
  <reference>
    <citation>WHO. TB Country Profile for Zambia: Surveillance and Epidemiology. 2009 [cited; Available from: http://apps.who.int/globalatlas/predefinedReports/TB/PDF_Files/zmb.pdf</citation>
  </reference>
  <reference>
    <citation>Ayles H, Schaap A, Nota A, Sismanidis C, Tembwe R, De Haas P, Muyoyeta M, Beyers N; Peter Godfrey-Faussett for the ZAMSTAR Study Team. Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV. PLoS One. 2009;4(5):e5602. doi: 10.1371/journal.pone.0005602. Epub 2009 May 19.</citation>
    <PMID>19440346</PMID>
  </reference>
  <reference>
    <citation>Tripathy SN, Tripathy SN. Tuberculosis and pregnancy. Int J Gynaecol Obstet. 2003 Mar;80(3):247-53.</citation>
    <PMID>12628525</PMID>
  </reference>
  <reference>
    <citation>Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997 May 3;349(9061):1269-76.</citation>
    <PMID>9142060</PMID>
  </reference>
  <reference>
    <citation>Harries AD, Parry C, Nyongonya Mbewe L, Graham SM, Daley HM, Maher D, Salaniponi FM, Nyangulu DS. The pattern of tuberculosis in Queen Elizabeth Central Hospital, Blantyre, Malawi: 1986-1995. Int J Tuberc Lung Dis. 1997 Aug;1(4):346-51.</citation>
    <PMID>9432391</PMID>
  </reference>
  <reference>
    <citation>Khan M, Pillay T, Moodley JM, Connolly CA; Durban Perinatal TB HIV-1 Study Group. Maternal mortality associated with tuberculosis-HIV-1 co-infection in Durban, South Africa. AIDS. 2001 Sep 28;15(14):1857-63.</citation>
    <PMID>11579249</PMID>
  </reference>
  <reference>
    <citation>WHO. Fact Sheet- Women and TB; 2009. 2009 [cited; Available from: http://www.stoptb.org/resource_center/assets/factsheets/womenandtb.pdf</citation>
  </reference>
  <reference>
    <citation>Pillay T, Khan M, Moodley J, Adhikari M, Padayatchi N, Naicker V, Pillay DG, Coovadia HM. The increasing burden of tuberculosis in pregnant women, newborns and infants under 6 months of age in Durban, KwaZulu-Natal. S Afr Med J. 2001 Nov;91(11):983-7.</citation>
    <PMID>11847922</PMID>
  </reference>
  <reference>
    <citation>Celine R. Gounder, M., ScM*, Nikolas Wada, MPH*, Caroline Kensler, MHS*, Avy Violari, MD**, Richard E. Chaisson, MD*, James McIntyre, MBChB, FRCOG***, Neil Martinson, MBChB, MPH*,**, Provider-Initiated Screening for Tuberculosis (TB) among Pregnant Women in Antenatal Clinics in Soweto, South Africa, in 17th Conference on Retroviruses and Opportunistic Infections. 2010: San Francisco, CA. February 16 - 19 2010.</citation>
  </reference>
  <reference>
    <citation>Kali PB, Gray GE, Violari A, Chaisson RE, McIntyre JA, Martinson NA. Combining PMTCT with active case finding for tuberculosis. J Acquir Immune Defic Syndr. 2006 Jul;42(3):379-81.</citation>
    <PMID>16645548</PMID>
  </reference>
  <reference>
    <citation>Gupta A, Nayak U, Ram M, Bhosale R, Patil S, Basavraj A, Kakrani A, Philip S, Desai D, Sastry J, Bollinger RC; Byramjee Jeejeebhoy Medical College-Johns Hopkins University Study Group. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005. Clin Infect Dis. 2007 Jul 15;45(2):241-9. Epub 2007 Jun 4.</citation>
    <PMID>17578786</PMID>
  </reference>
  <reference>
    <citation>Ahmed Y, Mwaba P, Chintu C, Grange JM, Ustianowski A, Zumla A. A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death. Int J Tuberc Lung Dis. 1999 Aug;3(8):675-80.</citation>
    <PMID>10460099</PMID>
  </reference>
  <reference>
    <citation>Margono F, Mroueh J, Garely A, White D, Duerr A, Minkoff HL. Resurgence of active tuberculosis among pregnant women. Obstet Gynecol. 1994 Jun;83(6):911-4.</citation>
    <PMID>8190429</PMID>
  </reference>
  <reference>
    <citation>Bjerkedal T, Bahna SL, Lehmann EH. Course and outcome of pregnancy in women with pulmonary tuberculosis. Scand J Respir Dis. 1975;56(5):245-50.</citation>
    <PMID>1209197</PMID>
  </reference>
  <reference>
    <citation>Figueroa-Damian R, Arredondo-Garcia JL. Pregnancy and tuberculosis: influence of treatment on perinatal outcome. Am J Perinatol. 1998 May;15(5):303-6.</citation>
    <PMID>9643636</PMID>
  </reference>
  <reference>
    <citation>Jana N, Vasishta K, Jindal SK, Khunnu B, Ghosh K. Perinatal outcome in pregnancies complicated by pulmonary tuberculosis. Int J Gynaecol Obstet. 1994 Feb;44(2):119-24.</citation>
    <PMID>7911094</PMID>
  </reference>
  <reference>
    <citation>Pillay T, Khan M, Moodley J, Adhikari M, Coovadia H. Perinatal tuberculosis and HIV-1: considerations for resource-limited settings. Lancet Infect Dis. 2004 Mar;4(3):155-65. Review.</citation>
    <PMID>14998501</PMID>
  </reference>
  <reference>
    <citation>Amita Gupta, N.G., Sandesh Patil, Pradeep Sambarey, Sandhya Khadse, Anju Kagal, Suvarna Joshi, Arun Jamkar, Robert Bollinger, and the SWEN India Study Group1Johns, Maternal TB is associated with increased risk of HIV mother-to-child transmission, in 17th Conference on Retroviruses and Opportunistic Infections. 2010: San Francisco, CA. February 16 - 19 2010</citation>
  </reference>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2014</study_first_submitted>
  <study_first_submitted_qc>January 31, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2014</study_first_posted>
  <last_update_submitted>September 13, 2017</last_update_submitted>
  <last_update_submitted_qc>September 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tuberculosis</keyword>
  <keyword>HIV</keyword>
  <keyword>pregnancy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Tuberculosis, Pulmonary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

